Literature DB >> 11035068

IL-15 and IL-15 receptor selectively regulate differentiation of common mucosal immune system-independent B-1 cells for IgA responses.

T Hiroi1, M Yanagita, N Ohta, G Sakaue, H Kiyono.   

Abstract

We show in this report a new regulatory role for IL-15 and IL-15R in the development of B-1 cells and their differentiation into IgA-producing cells. Mucosal IgA levels were found to be inhibited by anti-IL-15 mAb treatment in vivo, but enhanced by administration of rIL-15, while serum IgA levels remained unaffected. Mucosal B-1 cells preferentially proliferated in response to IL-15 in vitro. When mucosal B-1 and B-2 cells were separated into surface (s)IgM(+)sIgA(-) and sIgM(-)sIgA(+) fractions, IL-15R-specific mRNA was found to be predominant in both sIgM(+)sIgA(-) and sIgM(-)sIgA(+) B-1 cells at a much higher level than B-2 cells. Further, incubation of these different subsets of B-1 and B-2 cells with IL-15 resulted in greater enhancement of the corresponding receptor expression by B-1 subset when compared with B-2 fraction. Interestingly, de novo isolated sIgM(+)sIgA(-) B-1, but not sIgM(+)sIgA(-) B-2, cells were already class-switched cells because the germline Calpha transcript was detected and was then further enhanced by IL-15. IL-15 also supported differentiation of both sIgM(+)sIgA(-) and sIgM(-)sIgA(+) B-1 cells into IgA-producing cells. Taken together, these findings suggest that IL-15 is a critically important cytokine for the differentiation of both sIgM(+),IgA(-) and sIgM(-)sIgA(+) B-1 cells expressing IL-15R into IgA-producing cells in mucosal tissues.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11035068     DOI: 10.4049/jimmunol.165.8.4329

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Transgenic mice that overexpress human IL-15 in enterocytes recapitulate both B and T cell-mediated pathologic manifestations of celiac disease.

Authors:  Seiji Yokoyama; Kazuko Takada; Masatomo Hirasawa; Liyanage P Perera; Takachika Hiroi
Journal:  J Clin Immunol       Date:  2011-09-22       Impact factor: 8.317

2.  Codelivery of CCR7 ligands as molecular adjuvants enhances the protective immune response against herpes simplex virus type 1.

Authors:  Felix N Toka; Malgorzata Gierynska; Barry T Rouse
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

3.  Utilizing IL-12, IL-15 and IL-7 as Mucosal Vaccine Adjuvants.

Authors:  Liljana Stevceva; Marcin Moniuszko; Maria Grazia Ferrari
Journal:  Lett Drug Des Discov       Date:  2006       Impact factor: 1.150

4.  IL-15 temporally reorients IL-10 biased B-1a cells toward IL-12 expression.

Authors:  Amlan Kanti Ghosh; Debolina Sinha; Subhadeep Mukherjee; Ratna Biswas; Tapas Biswas
Journal:  Cell Mol Immunol       Date:  2015-03-09       Impact factor: 11.530

5.  Regulation of synthesis of osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand in normal human osteoblasts via the p38 mitogen-activated protein kinase pathway by the application of cyclic tensile strain.

Authors:  Akinori Kusumi; Hirotaka Sakaki; Tomomi Kusumi; Mitsuo Oda; Kenji Narita; Hiroshi Nakagawa; Kohsei Kubota; Hisashi Satoh; Hiroto Kimura
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

6.  Recombinant rabies virus expressing IL-15 enhances immunogenicity through promoting the activation of dendritic cells in mice.

Authors:  Tiange Chen; Yajing Zhang; Zhao Wang; Jie Yang; Mingming Li; Kunlun Wang; Min Cui; Zhen F Fu; Ling Zhao; Ming Zhou
Journal:  Virol Sin       Date:  2017-08-29       Impact factor: 4.327

7.  Interleukin-15 and its receptor augment dendritic cell vaccination against the neu oncogene through the induction of antibodies partially independent of CD4 help.

Authors:  Jason C Steel; Charmaine A Ramlogan; Ping Yu; Yoshio Sakai; Guido Forni; Thomas A Waldmann; John C Morris
Journal:  Cancer Res       Date:  2010-01-19       Impact factor: 12.701

8.  An intranasal heat shock protein based vaccination strategy confers protection against mucosal challenge with herpes simplex virus.

Authors:  Christopher D Pack; Malgorzata Gierynska; Barry T Rouse
Journal:  Hum Vaccin       Date:  2008-09-28

9.  Intestinal villous M cells: an antigen entry site in the mucosal epithelium.

Authors:  Myoung Ho Jang; Mi-Na Kweon; Koichi Iwatani; Masafumi Yamamoto; Kazutaka Terahara; Chihiro Sasakawa; Toshihiko Suzuki; Tomonori Nochi; Yoshifumi Yokota; Paul D Rennert; Takachika Hiroi; Hiroshi Tamagawa; Hideki Iijima; Jun Kunisawa; Yoshikazu Yuki; Hiroshi Kiyono
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-07       Impact factor: 11.205

10.  A multi-valent vaccinia virus-based tuberculosis vaccine molecularly adjuvanted with interleukin-15 induces robust immune responses in mice.

Authors:  Pin-Yu Perera; Steven C Derrick; Kristopher Kolibab; Fumiki Momoi; Masafumi Yamamoto; Sheldon L Morris; Thomas A Waldmann; Liyanage P Perera
Journal:  Vaccine       Date:  2009-02-06       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.